Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.
Center for Infectious Disease Dynamics, Pennsylvania State University, University Park, PA, USA.
BMC Med. 2021 Jan 5;19(1):2. doi: 10.1186/s12916-020-01843-z.
Through a combination of strong routine immunization (RI), strategic supplemental immunization activities (SIA) and robust surveillance, numerous countries have been able to approach or achieve measles elimination. The fragility of these achievements has been shown, however, by the resurgence of measles since 2016. We describe trends in routine measles vaccine coverage at national and district level, SIA performance and demographic changes in the three regions with the highest measles burden.
WHO-UNICEF estimates of immunization coverage show that global coverage of the first dose of measles vaccine has stabilized at 85% from 2015 to 19. In 2000, 17 countries in the WHO African and Eastern Mediterranean regions had measles vaccine coverage below 50%, and although all increased coverage by 2019, at a median of 60%, it remained far below levels needed for elimination. Geospatial estimates show many low coverage districts across Africa and much of the Eastern Mediterranean and southeast Asian regions. A large proportion of children unvaccinated for MCV live in conflict-affected areas with remote rural areas and some urban areas also at risk. Countries with low RI coverage use SIAs frequently, yet the ideal timing and target age range for SIAs vary within countries, and the impact of SIAs has often been mitigated by delays or disruptions. SIAs have not been sufficient to achieve or sustain measles elimination in the countries with weakest routine systems. Demographic changes also affect measles transmission, and their variation between and within countries should be incorporated into strategic planning.
Rebuilding services after the COVID-19 pandemic provides a need and an opportunity to increase community engagement in planning and monitoring services. A broader suite of interventions is needed beyond SIAs. Improved methods for tracking coverage at the individual and community level are needed together with enhanced surveillance. Decision-making needs to be decentralized to develop locally-driven, sustainable strategies for measles control and elimination.
通过常规免疫(RI)、战略补充免疫活动(SIA)和强大的监测相结合,许多国家已经能够接近或实现麻疹消除。然而,自 2016 年以来,麻疹的死灰复燃表明这些成就的脆弱性。我们描述了三个麻疹负担最重地区的国家和地区一级常规麻疹疫苗覆盖率、SIA 绩效和人口变化趋势。
世界卫生组织-联合国儿童基金会的免疫覆盖率估计显示,2015 年至 19 年期间,全球第一剂麻疹疫苗覆盖率稳定在 85%。2000 年,世卫组织非洲和东地中海区域的 17 个国家麻疹疫苗覆盖率低于 50%,尽管所有国家在 2019 年都提高了覆盖率,但中位数为 60%,仍远低于消除麻疹所需的水平。地理空间估计显示,非洲和东地中海以及东南亚大部分地区都有许多低覆盖率地区。很大一部分未接种 MCV 的儿童生活在受冲突影响的地区,偏远农村地区和一些城市地区也面临风险。常规免疫覆盖率低的国家经常使用 SIA,但 SIA 的理想时机和目标年龄范围在国家内部有所不同,SIA 的影响经常因延迟或中断而减弱。SIA 不足以在常规系统最薄弱的国家实现或维持麻疹消除。人口变化也会影响麻疹的传播,国家之间和国家内部的变化应纳入战略规划。
在 COVID-19 大流行之后重建服务提供了一个需要和机会,以增加社区参与规划和监测服务。除了 SIA 之外,还需要更广泛的干预措施。需要改进在个人和社区层面跟踪覆盖率的方法,同时加强监测。需要将决策权下放,以制定针对麻疹控制和消除的地方驱动、可持续战略。